Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

268 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Technosphere/Insulin--a new approach for effective delivery of human insulin via the pulmonary route.
Pfützner A, Mann AE, Steiner SS. Pfützner A, et al. Diabetes Technol Ther. 2002;4(5):589-94. doi: 10.1089/152091502320798204. Diabetes Technol Ther. 2002. PMID: 12450439 Clinical Trial.
Clinical and laboratory evaluation of specific chemiluminescence assays for intact and total proinsulin.
Pfützner A, Kunt T, Langenfeld M, Löbig M, Knesovic M, Forst T. Pfützner A, et al. Clin Chem Lab Med. 2003 Sep;41(9):1234-8. doi: 10.1515/CCLM.2003.189. Clin Chem Lab Med. 2003. PMID: 14598875
Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance.
Pfützner A, Langenfeld M, Kunt T, Löbig M, Forst T. Pfützner A, et al. Clin Lab. 2003;49(11-12):571-6. Clin Lab. 2003. PMID: 14651328
Fasting intact proinsulin is a highly specific predictor of insulin resistance in type 2 diabetes.
Pfützner A, Kunt T, Hohberg C, Mondok A, Pahler S, Konrad T, Lübben G, Forst T. Pfützner A, et al. Diabetes Care. 2004 Mar;27(3):682-7. doi: 10.2337/diacare.27.3.682. Diabetes Care. 2004. PMID: 14988285
Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus.
Pfützner A, Pfützner AH, Larbig M, Forst T. Pfützner A, et al. Among authors: pfutzner ah. Diabetes Technol Ther. 2004 Jun;6(3):405-12. doi: 10.1089/152091504774198124. Diabetes Technol Ther. 2004. PMID: 15198846 Review.
Evaluation of a new fully automated one-step C-peptide chemiluminescence assay (LIAISON C-Peptid).
Pfützner A, Löbig M, Fortunato A, Forst T. Pfützner A, et al. Clin Lab. 2003;49(5-6):227-32. Clin Lab. 2003. PMID: 15285178
Impact of posture and fixation technique on impedance spectroscopy used for continuous and noninvasive glucose monitoring.
Pfützner A, Caduff A, Larbig M, Schrepfer T, Forst T. Pfützner A, et al. Diabetes Technol Ther. 2004 Aug;6(4):435-41. doi: 10.1089/1520915041705839. Diabetes Technol Ther. 2004. PMID: 15320996
Intact and total proinsulin: new aspects for diagnosis and treatment of type 2 diabetes mellitus and insulin resistance.
Pfützner A, Kann PH, Pfützner AH, Kunt T, Larbig M, Weber MM, Forst T. Pfützner A, et al. Among authors: pfutzner ah. Clin Lab. 2004;50(9-10):567-73. Clin Lab. 2004. PMID: 15481632 Review.
Evaluation of SET--a new device for the measurement of pain perception in comparison to standard measures of diabetic neuropathy.
Nguyen M, Henniges W, Lobisch M, Reifert S, Larbig M, Pfützner A, Forst T. Nguyen M, et al. Among authors: pfutzner a. Diabetes Technol Ther. 2004 Oct;6(5):601-6. doi: 10.1089/dia.2004.6.601. Diabetes Technol Ther. 2004. PMID: 15628814
IRIS II Study: Sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance.
Langenfeld MR, Forst T, Standl E, Strotmann HJ, Lübben G, Pahler S, Kann P, Pfützner A; IRIS II study. Langenfeld MR, et al. Among authors: pfutzner a. Diabetes Technol Ther. 2004 Dec;6(6):836-43. doi: 10.1089/dia.2004.6.836. Diabetes Technol Ther. 2004. PMID: 15684637
268 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback